CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

BACKGROUND: Research suggests that measurable change in cerebrospinal fluid (CSF) biomarkers occurs years in advance of the onset of clinical symptoms (Beckett 2010). In this review, we aimed to assess the ability of CSF tau biomarkers (t‐tau and p‐tau) and the CSF tau (t‐tau or p‐tau)/ABeta ratio t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cochrane Database Syst Rev
Päätekijät: Ritchie, Craig, Smailagic, Nadja, Noel‐Storr, Anna H, Ukoumunne, Obioha, Ladds, Emma C, Martin, Steven
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Ltd 2017
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464349/
https://ncbi.nlm.nih.gov/pubmed/28328043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010803.pub2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia